Why It Matters

Blue Star Strategies LLC has filed a new client registration for Northern Scandinavia Inc., signed Nov. 13. The filing lists three issue areas: Health Issues, Advertising, and Consumer Issues/Safety/Protection. Its specific issue is to educate government officials about harm reduction and adult access to nicotine pouches approved by the U.S. Food and Drug Administration (FDA). ​

The filing carries a $0 filing amount and names no bill. The client has no earlier federal lobbying filings to compare it with.

Karen Tramontano, listed with the covered position of Chief Executive Officer, is the only lobbyist on the filing. Her profile lists 12 filings and two lobbying firms: Dutko Government Relations and Blue Star Strategies LLC.

Broader Context

The registration's specific issue concerns FDA-authorized nicotine pouches, and FDA has taken several actions on the category this year. On May 8, FDA said it would generally not prioritize enforcement against certain unauthorized nicotine-pouch products with accepted, pending applications, while keeping its focus on products with high nicotine content or serious safety concerns. On Aug. 4, it announced marketing authorization for four new nicotine-pouch products through its premarket review process. On Aug. 21, it said it had authorized 11 nicotine-pouch products made by Swedish Match USA.

On June 30, FDA allowed 20 specified ZYN products to carry a particular modified-risk claim. The announcement says the orders concern marketing claims, not a general authorization for all nicotine pouches. On July 14, the Public Health Law Center reported that public-health groups, pediatricians, and parents had challenged FDA's policy on certain unauthorized e-cigarettes and nicotine-pouch products.

The Bottom Line

The registration gives Northern Scandinavia one listed lobbyist on an issue where FDA has acted in several directions this year. It names no bill for Congress to consider.

Advertisement

Access the Legis1 platform for comprehensive political news, data, and insights.

Spot something wrong? Report an issue with this article